atosiban
PolandDrugs containing this active substance
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the frequency and strength of uterine contractions.
Form: solution for infusion, concentrate
Active substance Dosage atosiban 37.5 mg/5 ml ATC: G02CX01
Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Form: solution for injection in ampoule-syringe
Active substance Dosage atosiban 7.5 mg/ml ATC: G02CX01
Manufacturer: Accord Healthcare B.V. Accord Healthcare Polska Sp. z o.o.
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm birth. It works by reducing the strength and frequency of uterine contractions.
Form: solution for injection
Active substance Dosage atosiban 8.22 mg/ml ATC: G02CX01
Manufacturer: EVER Pharma Jena GmbH
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Form: solution for infusion, concentrate
Active substance Dosage atosiban 8.22 mg/ml ATC: G02CX01
Manufacturer: EVER Pharma Jena GmbH
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Form: solution for injection
Active substance Dosage atosiban 6.75 mg/0.9 ml ATC: G02CX01
Manufacturer: PHARMIDEA SIA
-
The medicine is used in pregnant women (from 24 to 33 weeks of gestation) to delay preterm labor. It works by reducing the strength and frequency of uterine contractions.
Form: solution for infusion, concentrate
Active substance Dosage atosiban 37.5 mg/5 ml ATC: G02CX01
Manufacturer: PHARMIDEA SIA